Eli Lilly Sues Compounding Pharmacies and Med Spas for Unapproved Diabetes Drug Sales Across Multiple States

Eli Lilly has initiated legal proceedings against various compounding pharmacies and medical spas across five states and the District of Columbia. The pharmaceutical giant alleges that these establishments deceive consumers into believing that they are purchasing Eli Lilly’s medications for diabetes and obesity, while in reality they are selling copycat drugs. These copycats, according to the suits, have not been tested by the U.S. Food and Drug Administration. Further details can be found [here](https://www.law360.com/articles/1849960/eli-lilly-launches-round-of-diabetes-drug-suits).